2004, Number S3
<< Back Next >>
Gac Med Mex 2004; 140 (S3)
VII. NAT and safety of the blood transfusion
González-Díez R
Language: Spanish
References: 8
Page: 86-89
PDF size: 35.89 Kb.
Text Extraction
No abstract
REFERENCES
Marshall DA, Kleinman SH, Wong JB, AuBuchon JP, Grima DT, Kulin NA et al. Cost-effectiveness of nucleic acid test screening of volunteer blood donations for hepatitis B, hepatitis C and human immunodeficiency virus in the United States. Vox Sang 2004; 86(1):28-40.
Kuehnert MJ, Roth VR, Haley NR, Gregory KR, Elder KV, Schreiber GB et al. Transfusion-transmitted bacterial infection in the United States, 1998 through 2000. Transfusion 2001; 41(12):1493-1499.
Alter HJ. Emerging, re-emerging and submerging infectious threats to the blood supply. Vox Sang 2004; 87 Suppl 2:56-61.
Busch MP, Kleinman SH, Jackson B, Stramer SL, Hewlett I, Preston S. Committee report. Nucleic acid amplification testing of blood donors for transfusion-transmitted infectious diseases: Report of the Interorganizational Task Force on Nucleic Acid Amplification Testing of Blood Donors. Transfusion 2000; 40(2):143-159.
Hernández JM. Riesgo residual de las enfermedades transmisibles por transfusión. Boletín de SETS. 2004.
Stramer SL, Glynn SA, Kleinman SH, Strong DM, Sally C, Wright DJ et al. Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic acid-amplification testing. N Engl J Med 2004;351(8):760-768.
Tabor E, Epstein JS. NAT screening of blood and plasma donations: evolution of technology and regulatory policy. Transfusion 2002;42(9):1230-1237.
International Forum. Implementation of donor screening for infectious agents transmitted by blood by nucleic acid technology. Vox Sang 2002;82:87-111.
Full text